Throughout history, plants have served as a crucial contributor to the treatment of diverse ailments, proving themselves to be foundational elements in the realm...
C2N Diagnostics, a leader in advanced brain health diagnostics, announced the release of the PrecivityAD2 blood test, a clinical care assay that meets the...
Company Provides Alzheimer’s Disease Patients Greater Access to Care through Administration of LEQEMBI In-home or On-site at its Infusion Centers
Soleo Health, an innovative leader and...
The US Food and Drug Administration (FDA) converted the approval process for Leqembi ( lecanemab-irmb), indicated for the treatment of adult patients with Alzheimer's...
ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS category leader, has announced the release of its AI-driven clinical suite, Neuro Suite. Purpose-built for...
